The drug-device combination market is expected to reach USD 177.7 billion by 2024, according to a new study by Grand View Research, Inc. The drug-device combination market is primarily driven by exponential growth in the production of advanced drug delivery devices coupled with the growing chronic disease burden, which is anticipated to be one of the primary... Continue Reading →